Skip to main content
Journal cover image

Reversible Opening of the Blood-Brain Barrier by Targeted Suppression of Claudin 5 To Enhance Drug Delivery into Brain Tumors

Publication ,  Conference
Grant, GA; Wilson, C; Campbell, M; Li, S; Humphries, P; Johnson, A; Dewhirst, M; Bigner, D
Published in: ANNALS OF NEUROLOGY
January 1, 2012

Duke Scholars

Published In

ANNALS OF NEUROLOGY

ISSN

0364-5134

Publication Date

January 1, 2012

Volume

72

Start / End Page

S144 / S144

Location

Boston, MA

Publisher

WILEY-BLACKWELL

Conference Name

137th Annual Meeting of the American-Neurological-Association (ANA)

Related Subject Headings

  • Neurology & Neurosurgery
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Grant, G. A., Wilson, C., Campbell, M., Li, S., Humphries, P., Johnson, A., … Bigner, D. (2012). Reversible Opening of the Blood-Brain Barrier by Targeted Suppression of Claudin 5 To Enhance Drug Delivery into Brain Tumors. In ANNALS OF NEUROLOGY (Vol. 72, pp. S144–S144). Boston, MA: WILEY-BLACKWELL.
Grant, Gerald A., Christy Wilson, Matthew Campbell, Shuqin Li, Peter Humphries, Allan Johnson, Mark Dewhirst, and Darell Bigner. “Reversible Opening of the Blood-Brain Barrier by Targeted Suppression of Claudin 5 To Enhance Drug Delivery into Brain Tumors.” In ANNALS OF NEUROLOGY, 72:S144–S144. WILEY-BLACKWELL, 2012.
Grant GA, Wilson C, Campbell M, Li S, Humphries P, Johnson A, et al. Reversible Opening of the Blood-Brain Barrier by Targeted Suppression of Claudin 5 To Enhance Drug Delivery into Brain Tumors. In: ANNALS OF NEUROLOGY. WILEY-BLACKWELL; 2012. p. S144–S144.
Grant, Gerald A., et al. “Reversible Opening of the Blood-Brain Barrier by Targeted Suppression of Claudin 5 To Enhance Drug Delivery into Brain Tumors.” ANNALS OF NEUROLOGY, vol. 72, WILEY-BLACKWELL, 2012, pp. S144–S144.
Grant GA, Wilson C, Campbell M, Li S, Humphries P, Johnson A, Dewhirst M, Bigner D. Reversible Opening of the Blood-Brain Barrier by Targeted Suppression of Claudin 5 To Enhance Drug Delivery into Brain Tumors. ANNALS OF NEUROLOGY. WILEY-BLACKWELL; 2012. p. S144–S144.
Journal cover image

Published In

ANNALS OF NEUROLOGY

ISSN

0364-5134

Publication Date

January 1, 2012

Volume

72

Start / End Page

S144 / S144

Location

Boston, MA

Publisher

WILEY-BLACKWELL

Conference Name

137th Annual Meeting of the American-Neurological-Association (ANA)

Related Subject Headings

  • Neurology & Neurosurgery
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences